E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/28/2012 in the Prospect News PIPE Daily.

MDxHealth to conduct €10 million private placement of ordinary stock

ING Belgium and Petercam are the bookrunners; deal will settle June 29

By Devika Patel

Knoxville, Tenn., June 28 - MDxHealth SA said it will raise about €10 million in a private placement of shares. The deal may be increased.

ING Belgium NV/SA and Petercam NV/SA are joint bookrunners.

Settlement is expected June 29.

Proceeds will be used to support and scale-up a U.S.-based sales and marketing team, operate and scale-up the company's U.S.-based CLIA-registered commercial laboratory and accelerate product development.

MDxHealth is a Liege, Belgium, molecular diagnostics company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.